Pomalyst monopoly case: Bristol Myers wins dismissal of lawsuit Ruchika Sharma13 April 2025 11:00 AM ISTA federal judge in New York has dismissed a proposed class action against pharmaceutical giant Bristol Myers Squibb, which accused the company of...
AbbVie blood cancer combo therapy fails in late-stage study Ruchika Sharma2 Oct 2023 1:00 PM ISTUnited States: AbbVie has said a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully...
Bristol Myers Squibb accused of illegal tactics to keep blood cancer drug Pomalyst monopoly in lawsuit Ruchika Sharma7 Sept 2023 1:30 PM ISTBristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on...
Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada Ruchika Sharma1 March 2023 12:15 PM ISTMultiple myeloma, commonly referred to as myeloma, is a cancer of plasma cells.
Natco Pharma unveils first generic version of Pomalyst capsules in Australia Ruchika Sharma9 Nov 2022 4:01 PM ISTPomalidomide is prescribed for treatment of Multiple Myeloma and Kaposi Sarcoma.
